We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$3.34B
AUM Growth
+$55.7M
Cap. Flow
-$245M
Cap. Flow %
-7.35%
Top 10 Hldgs %
37.4%
Holding
52
New
3
Increased
4
Reduced
36
Closed
2

Top Buys

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$116M
2
WBD icon
Warner Bros
WBD
+$111M
3
GILD icon
Gilead Sciences
GILD
+$397K
4
BDX icon
Becton Dickinson
BDX
+$361K
5
APA icon
APA Corp
APA
+$347K

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$108M
2
CSCO icon
Cisco
CSCO
+$85.8M
3
FDX icon
FedEx
FDX
+$24.4M
4
ETN icon
Eaton
ETN
+$18.2M
5
DD icon
DuPont de Nemours
DD
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.62%
2 Industrials 14.5%
3 Communication Services 13.21%
4 Energy 11.47%
5 Technology 10.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
26
DELISTED
Celgene Corp
CELG
$90.8M 2.72%
1,074,532
-170,466
-14% -$13.5M
MSFT icon
27
Microsoft
MSFT
$3.66T
$87.9M 2.63%
2,349,621
-238,704
-9% -$8.67M
QCOM icon
28
Qualcomm
QCOM
$171B
$85.3M 2.56%
1,148,687
-95,050
-8% -$6.7M
ORCL icon
29
Oracle
ORCL
$442B
$85.2M 2.56%
2,227,868
-176,071
-7% -$6.05M
ABT icon
30
Abbott
ABT
$192B
$41.8M 1.25%
1,089,663
-73,345
-6% -$2.7M
AMGN icon
31
Amgen
AMGN
$225B
$39.1M 1.17%
342,848
-26,025
-7% -$2.96M
MDLZ icon
32
Mondelez International
MDLZ
$79.4B
$10.7M 0.32%
302,250
-24,000
-7% -$798K
TE
33
DELISTED
TECO ENERGY INC
TE
$9.69M 0.29%
562,200
-28,100
-5% -$480K
ADP icon
34
Automatic Data Processing
ADP
$107B
$5.3M 0.16%
74,718
+2,050
+3% +$138K
APA icon
35
APA Corp
APA
$14B
$5.25M 0.16%
61,100
+3,900
+7% +$347K
UNP icon
36
Union Pacific
UNP
$174B
$2.67M 0.08%
31,800
– –
FE icon
37
FirstEnergy
FE
$27.2B
$2.6M 0.08%
78,900
+2,500
+3% +$88.1K
ZBH icon
38
Zimmer Biomet
ZBH
$18.7B
$2.32M 0.07%
25,647
-103
-0.4% -$8.91K
GILD icon
39
Gilead Sciences
GILD
$168B
$2.13M 0.06%
28,400
+5,700
+25% +$397K
A icon
40
Agilent Technologies
A
$41.9B
$1.98M 0.06%
48,371
-4,194
-8% -$159K
BMY icon
41
Bristol-Myers Squibb
BMY
$130B
$1.62M 0.05%
30,500
– –
CL icon
42
Colgate-Palmolive
CL
$73.6B
$1.16M 0.03%
17,800
– –
UNH icon
43
UnitedHealth
UNH
$364B
$956K 0.03%
12,700
– –
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.09T
$889K 0.03%
7,500
– –
PEP icon
45
PepsiCo
PEP
$189B
$680K 0.02%
8,200
-100
-1% -$8.3K
PG icon
46
Procter & Gamble
PG
$335B
$615K 0.02%
7,550
– –
ABBV icon
47
AbbVie
ABBV
$440B
$449K 0.01%
8,500
-859
-9% -$42.2K
BDX icon
48
Becton Dickinson
BDX
$50B
$376K 0.01%
+3,485
New +$361K
CSX icon
49
CSX Corp
CSX
$92.8B
$351K 0.01%
36,600
-3,600
-9% -$32.3K
HON icon
50
Honeywell
HON
$74.6B
$274K 0.01%
3,339
– –
1
2
3

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Stralem & Co held 52 positions worth $3.34B, up 1.7% from $3.28B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Stralem & Co withdrew a net $245M in Q4 2013, closing 2 positions and reducing 36 holdings. Its most notable exit was McDonald's, an estimated $108M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Stralem & Co opened a new position in Starbucks worth $115M.

  • Stralem & Co's largest Q4 2013 buy was Starbucks: 2,930,206 shares worth $115M.
  • Stralem & Co added most to Gilead Sciences in Q4 2013, an estimated $397K increase.
  • Stralem & Co's biggest Q4 2013 reduction was FedEx, cutting an estimated $24.4M.
  • Stralem & Co fully exited McDonald's in Q4 2013, selling an estimated $108M.
  • Stralem & Co's ten largest holdings make up 37% of its $3.34B portfolio in Q4 2013.
  • Stralem & Co opened 3 new positions and closed 2 in Q4 2013.
  • Stralem & Co's portfolio value rose 1.7% quarter-over-quarter to $3.34B.

Based on Stralem & Co's 13F filing for Q4 2013, filed 24 Jan 2014.